|Place of Origin:||China|
|Certification:||ISO, 9001, USP|
|Minimum Order Quantity:||1grams|
|Price:||Discount is possible if your order is big enough|
|Packaging Details:||10g, 20g, 50g , 100g, 500g. 1kg, 10kg|
|Delivery Time:||within 2 working days|
|Payment Terms:||T/T in advance, Money Gram, Western Union, Bank Transfer.|
|Model:||41100-52-1||Apparence:||White Or White-like Crystal Powder|
|Grade:||Pharma Grade||Stock:||Enough Stock|
pharmaceutical raw material,
chemical raw material
Pharmaceutical Raw Materials Memantine Hydrochloride HCl Powder CAS 41100-52-1
Just try a small order to start our cooperation, we will NOT make you down !
Any products interested pls let me know I will give info.in details.
Synonyms: Memantine HCL;1,3-Dimethyl-5-Aminoadamantane Hydrochloride;1,3-Dimethylaminoadamantane Hydrochloride;1-Amino-3,5-Dimethyladamantane Hcl;1-Amino-3,5-Dimethyladamantane Hydrochloride;1-Amino-3,4-Dimethyladamantane Hydrochloride
Melting point:292 °C
Chemical Properties:White Crystalline Solid
|Usages 1.||Used as an antiparkinsonian and antispasmodic.|
|Usages 2.|| Product Categories: Adamantane derivatives;Antispasmodic;Antiparkinsonian;Adamantanes;Intermediates & Fine Chemicals;Pharmaceuticals;Glutamate receptor;Glutamate;Amines;API;Other APIs;raw materials
hemical Properties Crystalline Solid
|Usages 3.||Used as an antiparkinsonian and antispasmodic|
|Usages 4.||Antiparkinsonian;Dopaminergic agonist|
|Usages 5.||Anti Alzheimer's|
Memantine HCl is the HCl form of Memantine. Memantine is a well- known neuroprotective drug used for the treatment of Alzheimer's disease. It is believed to be the first neuroprotective drug that has achieve clinical approval by US FDA as well as European. The development of Alzheimer's disease involves the misfolded mutant proteins such as β-amyloid peptide (Aβ, particularly Aβ1−42). These misfolded mutant protein can increase the NMDA response and further cause severe excitotoxicity. Memantine suppresses this process through acting as the antagonist of the N-methyl-d- aspartate-sensitive glutamate receptor (NMDARs). Memantine is also under investigation as a potential treatment for other kind of neurodegenerative disorders such as HIV-associated dementia, neuropathic pain, glaucoma, depression, Huntington's disease, ALS and movement disorders, among other.
Memantine HCL is an oral medication for the treatment of moderate to severe dementia associated with Alzheimer's. Memantine HCL's effects are independent of acetylcholine and acetylcholinesterase.
It is believed that too much stimulation of nerve cells by glutamate may be responsible for the degeneration of nerves that occurs in some neurological diseases such as Alzheimer's disease. Glutamate is produced and released by nerve cells in the brain. The released glutamate then travels to nearby nerve cells where it attaches to a receptor on the surface of the cells called the N-methyl-D-aspartate (NMDA) receptor.
Memantine HCL blocks this receptor and thereby decreases the effects of glutamate. It is thought that by blocking the NMDA receptor and the effects of glutamate, memantine may protect nerve cells from excess stimulation by glutamate.
Memantine hydrochloride is a kind of pharmaceutical raw materials, into a tablet called "easy times Shen, the product should be on the diagnosis and treatment of Alzheimer type dementia experienced prescription and guide the patients to use. There are patients with medication on time to supervise the case of starting treatment of caregivers. Dementia should be diagnosed in accordance with current diagnostic criteria and guidelines.